Onconova Therapeutics- Warrants (01/08/2021) Profit Margin

Onconova Therapeutics- Warrants (01/08/2021) (ONTXW) currently reports a profit margin of 321546.12% as of March 2026. That compares with -8797.22% in the prior-year period — up 3755.1% year over year. That is above the Healthcare sector average of 13.89%. Use the charts on this page to explore Onconova Therapeutics- Warrants (01/08/2021)'s profit margin history and peer comparisons.

Onconova Therapeutics- Warrants (01/08/2021)'s profit margin increased from -8797.22% to 321546.12% — a 3755.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Onconova Therapeutics- Warrants (01/08/2021)'s profit margin of 321546.12% is higher than the Healthcare sector average of 13.89%. That is roughly 2314334.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Onconova Therapeutics- Warrants (01/08/2021)'s current 321546.12% should be judged against Healthcare norms (sector average: 13.89%) and against ONTXW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 321546.12%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Onconova Therapeutics- Warrants (01/08/2021), and consider following ONTXW for alerts when major investors trade the stock.